MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with S

Sirolimus

Sirolimus 1mg tablets

Use with caution

Stability notes for Sirolimus 1mg tablets

Light sensitive medicine. Store in light resistant container.   Manufacturer recommends storing in original container.
No stability data in MCAs available

Provenance

This recommendation is based on the products Rapamune 1mg tablets (Pfizer Limited).

Suppliers

Rapamune 1mg tablets (Pfizer Ltd)
Sirolimus 1mg tablets (Pfizer Ltd)

Sirolimus 2mg tablets

Use with caution

Stability notes for Sirolimus 2mg tablets

Light sensitive medicine. Store in light resistant container.   Manufacturer recommends storing in original container.
No stability data in MCAs available

Provenance

This recommendation is based on the products Rapamune 2mg tablets (Pfizer Limited).

Suppliers

Rapamune 2mg tablets (Pfizer Ltd)
Sirolimus 2mg tablets (Pfizer Ltd)

Sirolimus 500microgram tablets

Use with caution

Stability notes for Sirolimus 500microgram tablets

Light sensitive medicine. Store in light resistant container.   Manufacturer recommends storing in original container.
No stability data in MCAs available

Provenance

This recommendation is based on the products Rapamune 0.5mg tablets (Pfizer Limited).

Suppliers

Rapamune 0.5mg tablets (Pfizer Ltd)
Sirolimus 500microgram tablets (Pfizer Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.